300 related articles for article (PubMed ID: 36373970)
1. Increasing trends of colistin resistance in patients at high-risk of carbapenem-resistant
El-Mahallawy HA; El Swify M; Abdul Hak A; Zafer MM
Ann Med; 2022 Dec; 54(1):1-9. PubMed ID: 36373970
[TBL] [Abstract][Full Text] [Related]
2. Whole-genome sequence analysis of clinically isolated carbapenem resistant Escherichia coli from Iran.
Haeili M; Barmudeh S; Omrani M; Zeinalzadeh N; Kafil HS; Batignani V; Ghodousi A; Cirillo DM
BMC Microbiol; 2023 Feb; 23(1):49. PubMed ID: 36850019
[TBL] [Abstract][Full Text] [Related]
3.
Cebrero-Cangueiro T; Álvarez-Marín R; Labrador-Herrera G; Smani Y; Cordero-Matía E; Pachón J; Pachón-Ibáñez ME
Front Cell Infect Microbiol; 2018; 8():363. PubMed ID: 30406040
[TBL] [Abstract][Full Text] [Related]
4. Clinical carbapenem-resistant
Shahid M; Ahmad N; Saeed NK; Shadab M; Joji RM; Al-Mahmeed A; Bindayna KM; Tabbara KS; Dar FK
Front Cell Infect Microbiol; 2022; 12():1033305. PubMed ID: 36304935
[TBL] [Abstract][Full Text] [Related]
5. Comparative
Mirza HC; Güçlü AÜ; İnce Ceviz G; Başustaoğlu A
J Med Microbiol; 2022 Oct; 71(10):. PubMed ID: 36301611
[No Abstract] [Full Text] [Related]
6. High frequency of NDM-1 and OXA-48 carbapenemase genes among Klebsiella pneumoniae isolates in central Iran.
Abbasi E; Ghaznavi-Rad E
BMC Microbiol; 2023 Apr; 23(1):98. PubMed ID: 37038144
[TBL] [Abstract][Full Text] [Related]
7. Detection of VIM, NDM and OXA-48 producing carbapenem resistant Enterobacterales among clinical isolates in Southern Hungary.
Gajdács M; Ábrók M; Lázár A; Jánvári L; Tóth Á; Terhes G; Burián K
Acta Microbiol Immunol Hung; 2020 Dec; 67(4):209-215. PubMed ID: 33258795
[TBL] [Abstract][Full Text] [Related]
8. [In Vitro Activity of Ceftazidime-avibactam and Colistin Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates].
Hoşbul T; Aydoğan CN; Kaya S; Bedir O; Gümral R; Albay A
Mikrobiyol Bul; 2022 Apr; 56(2):218-229. PubMed ID: 35477226
[TBL] [Abstract][Full Text] [Related]
9. Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae from Bangkok, Thailand, and Their Detection by the Carba NP and Modified Carbapenem Inactivation Method Tests.
Laolerd W; Akeda Y; Preeyanon L; Ratthawongjirakul P; Santanirand P
Microb Drug Resist; 2018 Sep; 24(7):1006-1011. PubMed ID: 29782216
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activities of imipenem-colistin, imipenem-tigecycline, and tigecycline-colistin combinations against carbapenem-resistant Enterobacteriaceae.
Dundar D; Duymaz Z; Genc S; Er DK; İrvem A; Kandemir N
J Chemother; 2018; 30(6-8):342-347. PubMed ID: 30663555
[TBL] [Abstract][Full Text] [Related]
11. [The Epidemiology of Carbapenemases in Escherichia coli and Klebsiella pneumoniae Isolated in 2019 in Turkey].
Süzük Yıldız S; Şimşek H; Bakkaloğlu Z; Numanoğlu Çevik Y; Hekimoğlu CH; Kılıç S; Alp Meşe E;
Mikrobiyol Bul; 2021 Jan; 55(1):1-16. PubMed ID: 33590977
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of carbapenem-resistant
Yan WJ; Jing N; Wang SM; Xu JH; Yuan YH; Zhang Q; Li AL; Chen LH; Zhang JF; Ma B; Ma Q; Li Y
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33587030
[No Abstract] [Full Text] [Related]
13. A Comparative
Singh S; Sahu C; Patel SS; Singh A; Yaduvanshi N
Indian J Crit Care Med; 2020 Dec; 24(12):1213-1217. PubMed ID: 33446975
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers.
Martins AF; Bail L; Ito CAS; da Silva Nogueira K; Dalmolin TV; Martins AS; Rocha JLL; Serio AW; Tuon FF
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):228-232. PubMed ID: 29223516
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen.
Alsharapy SA; Gharout-Sait A; Muggeo A; Guillard T; Cholley P; Brasme L; Bertrand X; Moghram GS; Touati A; De Champs C
Microb Drug Resist; 2020 Mar; 26(3):211-217. PubMed ID: 31397629
[No Abstract] [Full Text] [Related]
16. Molecular characterization of carbapenem- resistant Enterobacteriaceae yields increasing rates of NDM-1 carbapenemases and colistin resistance in an OXA-48- endemic area.
Cizmeci Z; Aktas E; Otlu B; Acikgoz O; Ordekci S
J Chemother; 2017 Dec; 29(6):344-350. PubMed ID: 28486840
[TBL] [Abstract][Full Text] [Related]
17. Correlation of β-Lactamase Production and Colistin Resistance among Enterobacteriaceae Isolates from a Global Surveillance Program.
Bradford PA; Kazmierczak KM; Biedenbach DJ; Wise MG; Hackel M; Sahm DF
Antimicrob Agents Chemother; 2015 Dec; 60(3):1385-92. PubMed ID: 26666920
[TBL] [Abstract][Full Text] [Related]
18. [Investigation of Plasmid Mediated mcr Colistin Resistance Gene in Clinical Enterobacterales Isolates].
Özkaya E; Buruk CK; Tosun İ; Toraman B; Kaklıkkaya N; Aydın F
Mikrobiyol Bul; 2020 Apr; 54(2):191-202. PubMed ID: 32723275
[TBL] [Abstract][Full Text] [Related]
19.
Goel A; Gupta V; Singhal L; Palta S; Chander J
Indian J Med Res; 2021 Mar; 154(3):520-526. PubMed ID: 35345078
[TBL] [Abstract][Full Text] [Related]
20. Plazomicin activity against polymyxin-resistant Enterobacteriaceae, including MCR-1-producing isolates.
Denervaud-Tendon V; Poirel L; Connolly LE; Krause KM; Nordmann P
J Antimicrob Chemother; 2017 Oct; 72(10):2787-2791. PubMed ID: 29091226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
